Grassi Investment Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,450
Closed -$206K 132
2024
Q1
$206K Buy
+7,450
New +$195K 0.02% 119
2023
Q3
Sell
-8,000
Closed -$205K 125
2023
Q2
$205K Buy
+8,000
New +$190K 0.02% 120
2022
Q4
Sell
-9,100
Closed -$222K 123
2022
Q3
$222K Buy
9,100
+300
+3% +$8.31K 0.03% 113
2022
Q2
$236K Sell
8,800
-2,550
-22% -$82K 0.03% 117
2022
Q1
$444K Hold
11,350
0.05% 102
2021
Q4
$520K Hold
11,350
0.05% 104
2021
Q3
$538K Buy
11,350
+100
+0.9% +$4.67K 0.06% 104
2021
Q2
$521K Sell
11,250
-150
-1% -$6.79K 0.06% 104
2021
Q1
$500K Sell
11,400
-150
-1% -$6.81K 0.06% 100
2020
Q4
$474K Sell
11,550
-200
-2% -$7.8K 0.06% 97
2020
Q3
$438K Sell
11,750
-6,000
-34% -$221K 0.06% 100
2020
Q2
$611K Buy
+17,750
New +$551K 0.09% 88
2019
Q2
Sell
-31,350
Closed -$1.05M 123
2019
Q1
$1.05M Buy
+31,350
New +$987K 0.16% 80

Other funds holding FFTY

Grassi Investment Management's FFTY Position: Q2 2024 in Review

Grassi Investment Management sold out of CapForce IBD 50 ETF (FFTY) in Q2 2024, closing a stake of 7,450 shares — an estimated $206K sold.

Grassi Investment Management first reported a position in FFTY in Q1 2019 and held it in 13 quarters. The position peaked at $1.05M in Q1 2019. 36 funds tracked by Wall St. Rank hold FFTY as of Q2 2024.

  • Grassi Investment Management reported no remaining CapForce IBD 50 ETF position as of Q2 2024 after selling out during the quarter.
  • Grassi Investment Management sold 7,450 CapForce IBD 50 ETF shares in Q2 2024, an estimated $206K.
  • Grassi Investment Management first reported a position in CapForce IBD 50 ETF in Q1 2019 and held it in 13 quarters.
  • Grassi Investment Management's CapForce IBD 50 ETF position peaked at $1.05M in Q1 2019.
  • 36 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2024.

Based on Grassi Investment Management's 13F filing for Q2 2024, filed 9 Jul 2024.